Aster DM Quality Care Share Price
786.75-0.25 (-0.03%)
+26.86% past 1 Year
Aster DM Healthcare Limited operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC
Corporate filings & documents
Announcements
Newspaper publication regarding intimation of 18th Annual General Meeting scheduled to be held on 28 September 2026
2 days agoNewspaper publication regarding intimation of 18th Annual General Meeting scheduled to be held on 28 September 2026
2 days agoIntimation regarding capacity expansion at facility of a material subsidiary of the Company
3 days agoIntimation regarding capacity expansion at facility of a material subsidiary of the Company
3 days agoIntimation of Scheme of Amalgamation of step down subsidiaries of the Company
5 days agoIntimation of Scheme of Amalgamation of step down subsidiaries of the Company
5 days agoAcquisition of Equity Shares of STS Holdings Limited by a Subsidiary of the Company
6 days agoAcquisition of Equity Shares of STS Holdings Limited by a Subsidiary of the Company
6 days agoNewspaper advertisement regarding dispatch of the Notice of Postal Ballot of the Company
1 week agoNewspaper advertisement regarding dispatch of the Notice of Postal Ballot of the Company
1 week agoNotice of Postal Ballot seeking approval of shareholders
1 week agoNotice of Postal Ballot seeking approval of shareholders
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DB Trustee (Hong Kong) Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DB Trustee (Hong Kong) Ltd
1 week agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 26 2026 for Union (Mauritius) Holdings Ltd
1 week agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 26 2026 for Union (Mauritius) Holdings Ltd
1 week agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 26 2026 for Union (Mauritius) Holdings Ltd
1 week agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 26 2026 for Union (Mauritius) Holdings Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for GLAS Trust (Singapore) Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for GLAS Trust (Singapore) Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
1 week agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
1 week agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 21 2026 for BCP Asia II Topco IV Pte Ltd
1 week agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on August 21 2026 for BCP Asia II Topco IV Pte Ltd
1 week agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 21 2026 for BCP Asia II Topco IV Pte Ltd
1 week agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 21 2026 for BCP Asia II Topco IV Pte Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for GLAS Trust (Singapore) Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for GLAS Trust (Singapore) Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Centella Mauritius Holdings Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Centella Mauritius Holdings Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Centella Mauritius Holdings Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Centella Mauritius Holdings Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoIntimation regarding receipt of trading approval for equity shares allotted in terms of Scheme of Amalgamation
2 weeks agoIntimation regarding receipt of trading approval for equity shares allotted in terms of Scheme of Amalgamation
2 weeks agoTranscript of earning conference call held for the quarter ended 30 June 2026
3 weeks agoTranscript of earning conference call held for the quarter ended 30 June 2026
3 weeks agoNewspaper publication regarding unaudited financial results for the quarter ended 30 June 2026
4 weeks agoNewspaper publication regarding unaudited financial results for the quarter ended 30 June 2026
4 weeks agoVideo/Audio Recording of Earnings Call for the quarter ended 30 June 2026
4 weeks agoIntimation that the Company will be participating in the Non-deal Roadshow organized by Kotak Mahindra Capital Company Limited from 10 August 2026 to 14 August 2026
4 weeks agoIntimation that the Company will be participating in the Non-deal Roadshow organized by Kotak Mahindra Capital Company Limited from 10 August 2026 to 14 August 2026
4 weeks agoAcquisition of equity shares of United CIIGMA Institute of Medical Sciences a Subsidiary Company of the Company
4 weeks agoAcquisition of equity shares of United CIIGMA Institute of Medical Sciences a Subsidiary Company of the Company
4 weeks agoApproval of Notice of 18th AGM and Postal Ballot and other required disclosures
4 weeks agoApproval of Notice of 18th AGM and Postal Ballot and other required disclosures
4 weeks agoPress release in relation to unaudited financial results for the quarter ended 30 June 2026
4 weeks agoConcalls & investor presentations
Aug 2026
May 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Oct 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-04-02
Dividend
3.0
2025-08-28
Dividend
1.0
2025-02-10
Dividend
4.0
2024-08-22
Dividend
2.0
2024-04-23
Dividend
118.0
Company details
Registered office
Awfis, 2nd Floor, Renaissance Centra 27 & 27/1, Mission Road Sampangi Rama Nagar Bengaluru Karnataka PIN: 560027 Tel No: 0484 6699999 Fax No: NULL Email: [email protected] / [email protected] Internet: www.asterdmhealthcare.in
Registrars
Surya, 35 Mayflower Avenue, Behind SenthilNagar, SowripalayamRoad , Coimbatore – 641028, TN IndiaPhone: +91 422 4958995,2539835-836Email: [email protected] Surya, 35 Mayflower Avenue Behind Senthil Nagar Sowripalayam Road PIN: Tel No: 91 422 4958995,2539835-836 Fax No: 0422 2539837 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Azad Moopen, Chairman & Managing Director
Azad Moopen, Chairman & Managing Director
Alisha Moopen, Deputy Managing Director
Purana Housdurgamvijaya Deepti, Non Executive Independent Director
Sunil Theckath Vasudevan, Non Executive Independent Director
Thadathil Joseph Wilson, Non Executive Director
James Mathew , Non Executive Independent Director
Hemish Purushottam, Company Secretary & Compliance Officer
Mandayapurath Azad Moopen, Executive Director
Varun Khanna, Managing Director
Neeraj Jain, Non Executive Independent Director
Kewal Handa, Non Executive Independent Director
Ayshwarya Vikram, Non Executive Director
V K Mathews, Non Executive Independent Director
Details
BSE 540975
NSE ASTERDM
ISIN INE914M01019